It’s the second time shareholders have blanched at additional reporting of abortion risks, despite ambiguity about providers’ legal requirements for providing care.
It’s the second time shareholders have blanched at additional reporting of abortion risks, despite ambiguity about providers’ legal requirements for providing care.